Novel Treatment for Rotator Cuff Tears

Sponsor
Mayo Clinic (Other)
Overall Status
Recruiting
CT.gov ID
NCT05590494
Collaborator
(none)
15
1
1
18.8
0.8

Study Details

Study Description

Brief Summary

The focus of this study is to examine changes in pain scores, strength, and range of motion over time following an ultrasonic tenotomy on a partial tear (<50%) of the supraspinatus tendon of the rotator cuff.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Ultrasonic tenotomy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Ultrasonic Tenotomy as a Treatment of Partial Rotator Cuff Tear of the Supraspinatus Tendon: A Pilot Feasibility Study
Actual Study Start Date :
Nov 7, 2022
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Repair a partially torn rotator cuff

Subjects will undergo an ultrasonic tenotomy to repair a partially torn rotator cuff per standard of care as clinically indicated

Procedure: Ultrasonic tenotomy
Ultrasonic procedure as part of standard of care, as clinically indicated, to stimulate healing of the partial tear. The procedure uses ultrasound guidance that allows a needlelike device to gradually break up and remove tendinopathic tendon tissue.

Outcome Measures

Primary Outcome Measures

  1. Change in pain [Baseline, 2, 6, 12 and 24-weeks post-procedure]

    Measured using a visual analog scale (VAS), used to measure subjective pain, rated from 0 (no pain) to 100 (most severe pain) at rest and during activity (previously painful activities)

  2. Change in shoulder active range of motion [Baseline, 2, 6, 12 and 24-weeks post-procedure]

    Measured using a goniometer reported in degrees

  3. Change in shoulder strength [Baseline, 2, 6, 12 and 24-weeks post-procedure]

    Assessed using a hand-held dynamometer (HHD) placed distally on the forearm, just proximal to the wrist joint along the distal radius and ulna with instruction to push into the HHD with maximum force production for approximately 5 seconds.

Secondary Outcome Measures

  1. Change in quality of life [Baseline, 2, 6, 12 and 24-weeks post-procedure]

    Measured using the SF-36 Quality of Life questionnaire which is a 36-item self-reported health survey that measures health and disability. Possible scores range from 0 to 100, with 0 indicating maximum disability, and 100 indicating no disability.

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Evidence of partial tear (< 50%) of the supraspinatus tendon on MRI.
Exclusion Criteria:
  • A tear of the supraspinatus tendon greater > 50% and any areas of full thickness tearing, concomitant tears > 25% of other rotator cuff tendons (infraspinatus, teres minor or subscapularis), or acute tear of the glenoid labrum.

  • Evidence of systemic illness/infection requiring oral or IV antibiotics during the recruitment period.

  • Evidence of overlying skin infection or lesion at the proposed device insertion point on the shoulder.

  • Previous corticosteroid injection within three months.

  • Those individuals less than 25 and greater than 75 years of age will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic Health System - Onalaska Onalaska Wisconsin United States 54650

Sponsors and Collaborators

  • Mayo Clinic

Investigators

  • Principal Investigator: Jacob Erickson, DO, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Jacob L. Erickson, Principal Investigator, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT05590494
Other Study ID Numbers:
  • 21-011522
First Posted:
Oct 21, 2022
Last Update Posted:
Dec 14, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jacob L. Erickson, Principal Investigator, Mayo Clinic
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 14, 2022